Division of Social Pharmacy, University of Helsinki, Finland.
J Patient Saf. 2012 Dec;8(4):165-76. doi: 10.1097/PTS.0b013e3182676cf3.
To explore the existence and characteristics of national and local medication error reporting (MER) systems and to describe national medication safety experts' perceptions of a good and effective MER system and barriers to reporting.
In a descriptive cross-sectional study, 32 medication safety experts were identified through member organizations of the International Pharmaceutical Federation in 88 countries and other professional organizations in 3 additional countries. These experts were invited to participate in an online survey.
Sixteen national medication safety experts from different countries participated in the study (response rate, 50%). A national (n = 5) or local (n = 6) MER system existed in 11 of these countries. In 5 countries, no MER system existed. The most common features of the MER systems were confidentiality of the reported information and providing feedback to those involved in reporting. Most experts perceived that a good and effective MER system was characterized by the opportunity to learn from errors by those involved in reporting, having a nonpunitive approach to reporting, and ease of use. They also perceived that a blame culture, lack of time, training, and coordination of reporting were the main barriers to reporting.
Blame culture, a lack of time, training and coordination of reporting continue to be the major barriers to reporting. Learning from errors and having a nonpunitive approach to reporting were thought to be the most critical features of a MER system. Difficulties in identifying national medication safety experts indicates a need for promoting international networking of medication safety experts and bodies for sharing information and learning from others.
探索国家和地方用药错误报告(MER)系统的存在和特点,并描述国家药物安全专家对良好和有效的 MER 系统的看法,以及报告的障碍。
在一项描述性的横断面研究中,通过国际药剂师联合会在 88 个国家的成员组织以及另外 3 个国家的其他专业组织确定了 32 名药物安全专家。邀请这些专家参加在线调查。
来自不同国家的 16 名国家药物安全专家参加了这项研究(应答率为 50%)。在这些国家中,有 11 个国家有国家(n=5)或地方(n=6)MER 系统。在 5 个国家,没有 MER 系统。MER 系统最常见的特点是报告信息的保密性和向报告参与者提供反馈。大多数专家认为,一个良好和有效的 MER 系统的特点是报告参与者有机会从错误中学习,对报告采取非惩罚性的方法,并且易于使用。他们还认为,指责文化、缺乏时间、报告的培训和协调是报告的主要障碍。
指责文化、缺乏时间、报告的培训和协调仍然是报告的主要障碍。从错误中学习和对报告采取非惩罚性的方法被认为是 MER 系统的最重要特征。确定国家药物安全专家的困难表明需要促进药物安全专家和机构的国际网络建设,以便分享信息和相互学习。